SCHEMBL29960977

SCHEMBL29960977

Nc1c(F)cccc1CO

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.41
IDO1 P14902 2/20 0.39
APOBEC3G Q9HC16 1/20 0.37
CHRNE Q04844 1/20 0.37
HPGD P15428 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MPO P05164 1/20 0.35
SLC6A4 P31645 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
AOC3 Q16853 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2717078 1.00 TAAR1 (0.41) TAAR1IDO1APOBEC3GCHRNEHPGD
SCHEMBL15390567 0.83 APOBEC3G (0.44) APOBEC3GCHRNEHPGDPDCD1CD274
SCHEMBL14354164 0.79 TAAR1 (0.48) TAAR1IDO1ALDH1A1MPOSLC6A4
SCHEMBL11144300 0.77 GABRA1 (0.44) TAAR1IDO1HPGDALDH1A1AOC3
SCHEMBL20822096 0.77 TAAR1 (0.41) TAAR1IDO1HPGDALDH1A1AOC3
Hydrochloric Acid SCHEMBL14354512 0.77 TAAR1 (0.46) TAAR1IDO1MPOSLC6A4AOC3
SCHEMBL29061361 0.77 IDO1 (0.46) TAAR1IDO1ALDH1A1MPO
SCHEMBL112270 0.76 CES2 (0.43) TAAR1IDO1APOBEC3GPDCD1CD274
SCHEMBL720119 0.76 CYP3A4 (0.43) IDO1APOBEC3GCHRNEHPGDPDCD1
SCHEMBL20465748 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313041-A1 NOVEL CYCLOPENTAL[C]PYRROL NEGATIVE ALLOSTERIC MODULATORS OF NR2B Novartis AG (CH) 2024-02-07 EP disclosed
WO-2022204336-A1 NOVEL CYCLOPENTAL[C]PYRROL NEGATIVE ALLOSTERIC MODULATORS OF NR2B NOVARTIS AG (CH) 2022-09-29 WO disclosed